Serving leading biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving leading biopharmaceutical companies globally:
Generated: October 18, 2017
| Tradename: | 1 |
| Applicant: | 1 |
| Ingredient: | 1 |
| Patents: | 8 |
| Formulation / Manufacturing: | see details |
| Mechanism of Action | Adrenergic beta-Antagonists Adrenergic alpha-Agonists |
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
COMBIGAN |
brimonidine tartrate; timolol maleate |
SOLUTION/DROPS;OPHTHALMIC | 021398 | NDA | Allergan, Inc. | 0023-9211 | 0023-9211-03 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-03) > 2.5 mL in 1 BOTTLE, DROPPER |
COMBIGAN |
brimonidine tartrate; timolol maleate |
SOLUTION/DROPS;OPHTHALMIC | 021398 | NDA | Allergan, Inc. | 0023-9211 | 0023-9211-05 | 1 BOTTLE, DROPPER in 1 CARTON (0023-9211-05) > 5 mL in 1 BOTTLE, DROPPER |
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.2%;EQ 0.5% BASE | ||||
| Approval Date: | Oct 30, 2007 | TE: | RLD: | Yes | |||||
| Patent: | ► Subscribe | Patent Expiration: | Apr 19, 2022 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY CONTROLLED IOP. DOSE IS ONE DROP OF COMBIGAN IN THE AFFECTED EYE TWICE DAILY | ||||||||
| Patent: | ► Subscribe | Patent Expiration: | Apr 19, 2022 | Product Flag? | Substance Flag? | Delist Request? | |||
| Patented Use: | REDUCTION OF ELEVATED INTRAOCULAR PRESSURE (IOP) IN PATIENTS WITH GLAUCOMA OR OCULAR HYPERTENSION WHO REQUIRE ADJUNCTIVE OR REPLACEMENT THERAPY DUE TO INADEQUATELY CONTROLLED IOP. DOSE IS ONE DROP OF COMBIGAN IN THE AFFECTED EYE TWICE DAILY | ||||||||
| Patent: | ► Subscribe | Patent Expiration: | Jan 19, 2023 | Product Flag? | Y | Substance Flag? | Delist Request? | Y | |
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Follow DrugPatentWatch:
Join the 22,924 others who get our Drug Patent Expiration Alerts:
